Literature DB >> 28948607

Synergistic interaction of the cannabinoid and death receptor systems - a potential target for future cancer therapies?

Attila Keresztes1, John M Streicher1.   

Abstract

Cannabinoid receptors have been shown to interact with other receptors, including tumor necrosis factor receptor superfamily (TNFRS) members, to induce cancer cell death. When cannabinoids and death-inducing ligands (including TNF-related apoptosis-inducing ligand) are administered together, they have been shown to synergize and demonstrate enhanced antitumor activity in vitro. Certain cannabinoid ligands have been shown to sensitize cancer cells and synergistically interact with members of the TNFRS, thus suggesting that the combination of cannabinoids with death receptor (DR) ligands induces additive or synergistic tumor cell death. This review summarizes recent findings on the interaction of the cannabinoid and DR systems and suggests possible clinical co-application of cannabinoids and DR ligands in the treatment of various malignancies.
© 2017 Federation of European Biochemical Societies.

Entities:  

Keywords:  TNF-related apoptosis-inducing ligand; apoptosis; cancer; cannabinoid; combination therapy; death receptor

Mesh:

Substances:

Year:  2017        PMID: 28948607     DOI: 10.1002/1873-3468.12863

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  2 in total

1.  Cannabinoid WIN 55,212-2 Inhibits Human Glioma Cell Growth by Triggering ROS-Mediated Signal Pathways.

Authors:  Kun Wang; Qian Wang; Qinghao Li; Zhaoqiang Zhang; Jing Gao; Cundong Fan; Baoliang Sun; Qingbin Ni
Journal:  Biomed Res Int       Date:  2021-04-22       Impact factor: 3.411

2.  Cytotoxic Effects of Cannabinoids on Human HT-29 Colorectal Adenocarcinoma Cells: Different Mechanisms of THC, CBD, and CB83.

Authors:  Daniela Cerretani; Giulia Collodel; Antonella Brizzi; Anna Ida Fiaschi; Andrea Menchiari; Elena Moretti; Laura Moltoni; Lucia Micheli
Journal:  Int J Mol Sci       Date:  2020-08-01       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.